Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Esteban Gonzalez-Ballerga"'
Autor:
Manuel Mendizabal, Marcos Thompson, Esteban Gonzalez-Ballerga, Margarita Anders, Graciela E Castro-Narro, Mario G Pessoa, Hugo Cheinquer, Gabriel Mezzano, Ana Palazzo, Ezequiel Ridruejo, Valeria Descalzi, Jose A Velarde-Ruiz Velasco, Sebastian Marciano, Linda Muñoz, Maria I Schinoni, Jaime Poniachik, Rosalía Perazzo, Eira Cerda, Francisco Fuster, Adriana Varon, Sandro Ruiz García, Alejandro Soza, Cecilia Cabrera, Andres J Gomez-Aldana, Flor de María Beltrán, Solange Gerona, Daniel Cocozzella, Fernando Bessone, Nelia Hernández, Cristina Alonso, Melina Ferreiro, Florencia Antinucci, Aldo Torre, Bruna D Moutinho, Silvia Coelho Borges, Fernando Gomez, Maria Dolores Murga, Federico Piñero, Gisela F Sotera, Jhonier A Ocampo, Valeria A Cortés Mollinedo, Marcos Girala, Pedro Montes, Natalia Ratusnu, Claudia A Zuñagua, Lida Castillo, Mauricio Castillo Barradas, Rocío Chávez, Cláudia Ivantes, Julia Brutti, Laura Tenorio, Jorge Garavito, Katherine Zevallos, Fernando Contreras, Mirtha Infante, Emilia Vera-Pozo, Martín Tagle, Luis G Toro, Carlos A De La Rocha, Daniela Simian, Marcelo O Silva
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 101053- (2023)
Introduction and Objectives: To achieve WHO's goal of eliminating HCV, innovative strategies must be designed to diagnose and treat more patients. This study aimed to describe an implementation strategy to identify patients with HCV who were lost to
Externí odkaz:
https://doaj.org/article/00e5c24fd56e4ee3bbc9ddfbc61a2d4e
Autor:
Manuel Mendizabal, Ezequiel Ridruejo, Federico Piñero, Margarita Anders, Martín Padilla, Luis G. Toro, Aldo Torre, Pedro Montes, Alvaro Urzúa, Esteban Gonzalez Ballerga, María Dolores Silveyra, Douglas Michelato, Javier Díaz, Mirta Peralta, Josefina Pages, Sandro Ruiz García, Isabel Gutierrez Lozano, Yuridia Macias, Daniel Cocozzella, Norberto Chavez-Tapia, Martín Tagle, Alejandra Dominguez, Adriana Varón, Emilia Vera Pozo, Fátima Higuera-de la Tijera, Carla Bustios, Damián Conte, Nataly Escajadillo, Andrés J Gómez, Laura Tenorio, Mauricio Castillo Barradas, Maria Isabel Schinoni, Fernando Bessone, Fernando Contreras, Leyla Nazal, Abel Sanchez, Matías García, Julia Brutti, María Cecilia Cabrera, Godolfino Miranda-Zazueta, German Rojas, Maximo Cattaneo, Graciela Castro-Narro, Fernando Rubinstein, Marcelo O. Silva
Publikováno v:
Annals of Hepatology, Vol 25, Iss , Pp 100350- (2021)
Introduction and Objectives: Viral infections have been described to increase the risk of decompensation in patients with cirrhosis. We aimed to determine the effect of SARS-CoV-2 infection on outcome of hospitalized patients with cirrhosis and to co
Externí odkaz:
https://doaj.org/article/191e2d30a21d4cef87512614101d6622
Autor:
Esteban Gonzalez Ballerga, Andrea Paes de Lima, Pilar Carballo, Jorge Daruich, Fernando Barreyro, J.A. Sorda, Alejandra Avagnina
Publikováno v:
Alimentary Pharmacology & Therapeutics. 54:1202-1212
Ursodeoxycholic acid (UDCA) is the first-line therapy for primary biliary cholangitis (PBC). However, nearly 40% of patients have an incomplete response to UDCA. The addition of bezafibrate has shown biochemical benefit in this group of patients.To e
Autor:
Manuel Mendizabal, Marcos Thompson, Esteban Gonzalez‐Ballerga, Margarita Anders, Graciela E. Castro‐Narro, Mario G. Pessoa, Hugo Cheinquer, Gabriel Mezzano, Ana Palazzo, Ezequiel Ridruejo, Valeria Descalzi, Jose A. Velarde‐Ruiz Velasco, Sebastian Marciano, Linda Muñoz, Maria I. Schinoni, Jaime Poniachik, Rosalía Perazzo, Eira Cerda, Francisco Fuster, Adriana Varon, Sandro Ruiz García, Alejandro Soza, Cecilia Cabrera, Andres J. Gomez‐Aldana, Flor de María Beltrán, Solange Gerona, Daniel Cocozzella, Fernando Bessone, Nelia Hernández, Cristina Alonso, Melina Ferreiro, Florencia Antinucci, Aldo Torre, Bruna D. Moutinho, Silvia Coelho Borges, Fernando Gomez, Maria Dolores Murga, Federico Piñero, Gisela F. Sotera, Jhonier A. Ocampo, Valeria A. Cortés Mollinedo, Daniela Simian, Marcelo O. Silva
Publikováno v:
Journal of viral hepatitisREFERENCES.
To achieve WHO's goal of eliminating hepatitis C virus (HCV), innovative strategies must be designed to diagnose and treat more patients. Therefore, we aimed to describe an implementation strategy to identify patients with HCV who were lost to follow
Autor:
María Eugenia Inzaugarat, Elena De Matteo, Placida Baz, Diego Lucero, Cecilia Claudia García, Esteban Gonzalez Ballerga, Jorge Daruich, Juan Antonio Sorda, Miriam Ruth Wald, Alejandra Claudia Cherñavsky
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172900 (2017)
INTRODUCTION:The immune system acts on different metabolic tissues that are implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Leptin and linoleic acid have the ability to potentially affect immune cells, whereas curcumin is
Externí odkaz:
https://doaj.org/article/b85f94be1e914fa48100f7fafb7a4741
Autor:
Andrea Curia, Maria Cielo Gutierrez, Cynthia Laura Musso, Jorge Daruich, Juan Antonio Sorda, Esteban Gonzalez Ballerga
Publikováno v:
Annals of Hepatology. 28:100952
Autor:
Jhon Prieto Ortiz, Joseph Akambase, Angelo Mattos, Enrique Carrera Estupinan, Javier Diaz Ferrer, Andre Curia, Patricia Gallardo, Esteban Gonzalez Ballerga, Domingo Balderramo, Jose Debes
Publikováno v:
Annals of Hepatology. 28:100991
Autor:
Jhon Prieto Ortiz, Joseph Akambase, Angelo Mattos, Enrique Carrera Estupinan, Javier Diaz Ferrer, Andre Curia, Patricia Gallardo, Esteban Gonzalez Ballerga, Domingo Balderramo, Jose Debes
Publikováno v:
Annals of Hepatology. 28:101042
Autor:
Maria Florencia Yamasato, Mariano Volpacchio, María Alejandra Avagnina, Enzo Rey, Alejandra Vellicce, Esteban Gonzalez Ballerga, Juan Antonio Sordá, Jorge Daruich
Publikováno v:
Annals of Hepatology. 28:100923
Autor:
J. Martín Aladio, Sara Berensztein, Florencia Yamasato, Juan Sordá, Oscar Grosso, Ariel K. Saad, Jorge Daruich, Esteban Gonzalez Ballerga
Publikováno v:
Revista Argentina de Cardiologia. 87:449-455
espanolIntroduccion: La hemocromatosis hereditaria es una enfermedad genetica que genera una sobrecarga sistemica de hierro, y en etapas avanzadas, puede afectar el corazon. El compromiso miocardico precoz por esta enfermedad no ha sido suficientemen